We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Beckman Coulter Life Sciences Distribution of Genedrive PLC COVID-19 Kit

Credit: Beckman Coulter

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Beckman Coulter Life Sciences Distribution of Genedrive PLC COVID-19 Kit"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA. It offers lyophilized reagents that enable product stability and allow for ambient shipping and storage. The easy to set up assay can streamline laboratory workflows, increase overall throughput, and decrease potential errors for assay set up. The Genedrive 96 SARS-CoV-2 kit has received the CE-IVD mark and is currently under FDA review for Emergency Use Authorization (EUA).

“Even as vaccines are being administered there is still a critical need to continue COVID-19 testing,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “This collaboration provides a turnkey solution for specialized laboratories looking to establish new or expanded test capacity with consumables and labor cost reduction. The ability to streamline the workflow by simultaneously preparing sample extraction and downstream assay set up is a critical step forward in advancing COVID testing workflows, increasing throughput and reducing consumables usage.”